CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates Myasthenia Gravis, a rare autoimmune disease affecting neuromuscular junctions. It aims to identify genetic and environmental risk factors, understand disease mechanisms, develop new diagnostic tools, and explore innovative therapies to improve patient outcomes and quality of life.
Myasthenia Gravis (MG) is a heterogeneous rare autoimmune neurological disease affecting the neuromuscular junction (NMJ).
The molecular events causing and maintaining MG are still unknown and current treatments do not lead to remission and entail considerable side-effects stressing the need for improved therapies.
We will address the: 1.
Natural course of disease: determine factors associated with disease onset and/or affecting the course of disease and patients' quality of life in subgroups of…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Athens
Type: Research institute
Activity type: Research Organisations
SME: No
Israel, Raanana
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
